Novartis Share Price Borsa Italiana
Stocks
CH0012005267
Pharmaceuticals
OTC Markets Traded| Market Cap | 29TCr 25TCr 24TCr 22TCr 41TCr 28,13900Cr 41TCr 2,79900Cr 1,09700Cr 14,07300Cr 1,10300Cr 1,07900Cr 46,87600Cr | P/E 2026 * |
21.9x | P/E 2027 * | 18.7x |
|---|---|---|---|---|---|
| Enterprise Value | 33TCr 28TCr 27TCr 24TCr 45TCr 31,31100Cr 46TCr 3,11500Cr 1,22100Cr 15,66000Cr 1,22700Cr 1,20000Cr 52,16200Cr | EV / Sales 2026 * |
5.66x | EV / Sales 2027 * | 5.25x |
| Free-Float |
91.66% | Yield 2026 * |
2.83% | Yield 2027 * | 2.95% |
Last Transcript: Novartis
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 01/02/2018 | |
Mukul Mehta
DFI | Director of Finance/CFO | - | 16/03/2026 |
Karen Hale
CMP | Compliance Officer | 58 | 14/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Nancy Andrews
BRD | Director/Board Member | 67 | 01/01/2015 |
| Director/Board Member | 69 | 01/01/2016 | |
Ton Büchner
BRD | Director/Board Member | 61 | 01/01/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 29TCr | |
| +3.60% | +0.88% | +75.59% | +124.32% | 1,05500Cr | |
| +3.33% | +4.35% | +53.82% | +57.17% | 63TCr | |
| +3.43% | +3.53% | +25.34% | +72.45% | 44TCr | |
| +1.35% | -2.17% | +40.98% | +41.50% | 35TCr | |
| +1.75% | -0.24% | +25.28% | +40.46% | 29TCr | |
| +2.13% | -0.32% | +0.58% | +10.77% | 24TCr | |
| +1.41% | +2.65% | +45.34% | +62.43% | 23TCr | |
| +1.35% | -3.53% | -14.72% | -52.63% | 20TCr | |
| +3.25% | +5.65% | +21.57% | +89.04% | 17TCr | |
| Average | +2.16% | +0.10% | +30.42% | +49.50% | 40.14TCr | |
| Weighted average by Cap. | +2.58% | +0.23% | +43.70% | +68.42% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.77TCr 4.98TCr 4.69TCr 4.26TCr 8.02TCr 5,52900Cr 8.13TCr 55TCr 22TCr 2,76500Cr 22TCr 21TCr 9,21100Cr | 6.13TCr 5.29TCr 4.98TCr 4.52TCr 8.51TCr 5,86900Cr 8.63TCr 58TCr 23TCr 2,93500Cr 23TCr 22TCr 9,77700Cr |
| Net income | 1.4TCr 1.2TCr 1.13TCr 1.03TCr 1.94TCr 1,33700Cr 1.97TCr 13TCr 5.21TCr 67TCr 5.24TCr 5.12TCr 2,22700Cr | 1.55TCr 1.34TCr 1.26TCr 1.14TCr 2.15TCr 1,48500Cr 2.18TCr 15TCr 5.79TCr 74TCr 5.82TCr 5.69TCr 2,47400Cr |
| Net Debt | 3.31TCr 2.86TCr 2.69TCr 2.45TCr 4.6TCr 3,17300Cr 4.67TCr 32TCr 12TCr 1,58700Cr 12TCr 12TCr 5,28600Cr | 2.78TCr 2.4TCr 2.26TCr 2.05TCr 3.86TCr 2,66500Cr 3.92TCr 27TCr 10TCr 1,33300Cr 10TCr 10TCr 4,44000Cr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
